The opportunity for an oral GLP-1 medication with highly effective weight loss that is simpler to take may provide increased access and opportunities for better health for our patients with obesity and diabetes, said Deborah Horn, DO, MPH, professor and director of obesity medicine at McGovern Medical School at UTHealth Houston and principal author of the study
Oral semaglutide and tirzepatide have similar guidancestop taking them 24 to 48 hours before surgery
Semaglutide and tirzepatide, with their longer dosing intervals, offer compelling advantages for patients needing intensive management
Journal of molecular endocrinology 53 , 105115, doi:10.1530/JME-13-0200 (2014)
Technology-assisted programs, including smartphone apps, web-based tools, and telehealth, are confirmed as valid delivery formats
Related Weight Loss Treatments Further Reading on Weight Loss Do Appetite Suppressants Work